Your browser doesn't support javascript.
loading
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.
Rosengren, S; Mellqvist, U-H; Nahi, H; Forsberg, K; Lenhoff, S; Strömberg, O; Ahlberg, L; Linder, O; Carlson, K.
Afiliação
  • Rosengren S; Department of Medical Sciences, Division of Hematology, Uppsala University Hospital, Uppsala, Sweden.
  • Mellqvist UH; Department of Hematology, South Elvsborg Hospital, Borås, Sweden.
  • Nahi H; Department of Hematology, Karolinska Institute, Stockholm, Sweden.
  • Forsberg K; Department of Hematology, Norrlands University Hospital, Umeå, Sweden.
  • Lenhoff S; Department of Hematology, Skåne University Hospital, Lund, Sweden.
  • Strömberg O; Department of Hematology, Karolinska Institute, Stockholm, Sweden.
  • Ahlberg L; Department of Hematology, Linköping University Hospital, Linköping, Sweden.
  • Linder O; Department of Hematology, Örebro University Hospital, Örebro, Sweden.
  • Carlson K; Department of Medical Sciences, Division of Hematology, Uppsala University Hospital, Uppsala, Sweden.
Bone Marrow Transplant ; 51(12): 1569-1572, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27694943

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Amiloidose de Cadeia Leve de Imunoglobulina / Melfalan Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Amiloidose de Cadeia Leve de Imunoglobulina / Melfalan Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article